BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 8950667)

  • 21. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in patient management. Hereditary colorectal cancers].
    Lakatos PL; Lakatos L
    Orv Hetil; 2006 Feb; 147(8):363-8. PubMed ID: 16579336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic cancer: epidemiology, genetics, and approaches to screening.
    Konner J; O'Reilly E
    Oncology (Williston Park); 2002 Dec; 16(12):1615-22, 1631-2; discussion 1632-3, 1637-8. PubMed ID: 12520639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics and prevention of pancreatic cancer.
    Vimalachandran D; Ghaneh P; Costello E; Neoptolemos JP
    Cancer Control; 2004; 11(1):6-14. PubMed ID: 14749618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer risks for men with BRCA1/2 mutations.
    Mahon SM
    Oncol Nurs Forum; 2014 Jan; 41(1):99-101. PubMed ID: 24368245
    [No Abstract]   [Full Text] [Related]  

  • 26. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary pancreatic cancer.
    Lynch HT; Brand RE; Deters CA; Shaw TG; Lynch JF
    Pancreatology; 2001; 1(5):466-71. PubMed ID: 12120226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic susceptibility to pancreatic cancer.
    Klein AP
    Mol Carcinog; 2012 Jan; 51(1):14-24. PubMed ID: 22162228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
    Talar-Wojnarowska R; Malecka-Panas E
    Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent deletions of tumor suppressor genes in pure pancreatic juice from patients with tumoral or nontumoral pancreatic diseases.
    Costentin L; Pagès P; Bouisson M; Berthelémy P; Buscail L; Escourrou J; Pradayrol L; Vaysse N
    Pancreatology; 2002; 2(1):17-25. PubMed ID: 12120000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods.
    Eskelinen MJ; Haglund UH
    Eur J Surg; 1999 Apr; 165(4):292-306. PubMed ID: 10365829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary gastrointestinal cancer.
    Hata K; Yamamoto Y; Kiyomatsu T; Tanaka T; Kazama S; Nozawa H; Kawai K; Tanaka J; Nishikawa T; Otani K; Yasuda K; Kishikawa J; Nagai Y; Anzai H; Shinagawa T; Arakawa K; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Watanabe T
    Surg Today; 2016 Oct; 46(10):1115-22. PubMed ID: 26676416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherited predisposition to cancer: a historical overview.
    Lynch HT; Shaw TG; Lynch JF
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):5-22. PubMed ID: 15264268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.
    Kim DH; Crawford B; Ziegler J; Beattie MS
    Fam Cancer; 2009; 8(2):153-8. PubMed ID: 18855126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multistep carcinogenesis in colorectal cancers.
    Takami K; Yana I; Kurahashi H; Nishisho I
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():190-6. PubMed ID: 8629105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial pancreatic cancer: a review.
    Lynch HT; Smyrk T; Kern SE; Hruban RH; Lightdale CJ; Lemon SJ; Lynch JF; Fusaro LR; Fusaro RM; Ghadirian P
    Semin Oncol; 1996 Apr; 23(2):251-75. PubMed ID: 8623061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
    Goggins M; Schutte M; Lu J; Moskaluk CA; Weinstein CL; Petersen GM; Yeo CJ; Jackson CE; Lynch HT; Hruban RH; Kern SE
    Cancer Res; 1996 Dec; 56(23):5360-4. PubMed ID: 8968085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.